Anesth Analg 1999;89:861
© 1999 International Anesthesia Research Society
CARDIOVASCULAR ANESTHESIA
A Meta-Analysis of the Effectiveness of Cell Salvage to Minimize Perioperative Allogeneic Blood Transfusion in Cardiac and Orthopedic Surgery
Charlotte Huët, MD*,
L. Rachid Salmi, MD, PhD*,
Dean Fergusson, MHA ,
Ankie W. M. M. Koopman-van Gemert, MD, PhD ,
Fraser Rubens, MD§,
Andreas Laupacis, MD , and
for the International Study of Perioperative Transfusion (ISPOT) Investigators,1
*INSERM U-330, Université Victor Segalen Bordeaux, Bordeaux, France;
Clinical Epidemiology Unit, Loeb Health Research Institute, University of Ottawa, Ottawa, Canada;
Hospital Gooi Noord, Blaricum, The Netherlands; and
§Ottawa Heart Institute, University of Ottawa, Ottawa, Canada
Address correspondence and reprint requests to Charlotte Huët, INSERM U-330, Université Victor Segalen Bordeaux 2, 146 rue Léo-Saignat, 33076 Bordeaux cedex, France.
Concern about risks of allogeneic transfusion has led to an interest in methods for decreasing perioperative transfusion. To determine whether cell salvage reduces patient exposure to allogeneic blood, we performed meta-analyses of randomized trials, evaluating the effectiveness and safety of cell salvage in cardiac or orthopedic elective surgery. The primary outcome was the proportion of patients who received at least one perioperative allogeneic red cell transfusion. Twenty-seven studies were included in the meta-analyses. Cell salvage devices that do not wash salvaged blood were marginally effective in cardiac surgery patients when used postoperatively (relative risk [RR] = 0.85, 95% confidence interval [CI] = 0.790.92). Devices that wash or do not wash salvaged blood considerably decreased the proportion of orthopedic surgery patients who received allogeneic transfusion (RR = 0.39, 95% CI = 0.300.51 and RR = 0.35, 95% CI 0.260.46, respectively). No studies of cell savers that wash salvaged blood during cardiac surgery were included. Cell salvage did not appear to increase the frequency of adverse events. We conclude that cell salvage in orthopedic surgery decreases the risk of patients exposure to allogeneic blood transfusion perioperatively. Postoperative cell salvage in cardiac surgery, with devices that do not wash the salvaged blood, is only marginally effective.
Implications: This meta-analysis of all published randomized trials provides the best current estimate of the effectiveness of cell salvage and is useful in guiding clinical practice. We conclude that cell salvage in orthopedic surgery decreases the proportion of patients requiring allogeneic blood transfusion perioperatively, but postoperative cell salvage is only marginally effective in cardiac surgery.
This article has been cited by other articles:

|
 |

|
 |
 
G. Wang, D. Bainbridge, J. Martin, and D. Cheng
The Efficacy of an Intraoperative Cell Saver During Cardiac Surgery: A Meta-Analysis of Randomized Trials
Anesth. Analg.,
August 1, 2009;
109(2):
320 - 330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. J. Gu, W. J. Vermeijden, A. J. de Vries, J. A. M. Hagenaars, R. Graaff, and W. van Oeveren
Influence of Mechanical Cell Salvage on Red Blood Cell Aggregation, Deformability, and 2,3-Diphosphoglycerate in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
Ann. Thorac. Surg.,
November 1, 2008;
86(5):
1570 - 1575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T. Tinmouth MD MSc, L. A. McIntyre MD MSc, and R. A. Fowler MDCM MS
Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients
Can. Med. Assoc. J.,
January 1, 2008;
178(1):
49 - 57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. Donahue, D. Gailani, M. S. Higgins, D. C. Drinkwater, and A. L. George Jr
Factor V Leiden Protects Against Blood Loss and Transfusion After Cardiac Surgery
Circulation,
February 25, 2003;
107(7):
1003 - 1008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. McGill, D. O'Shaughnessy, R. Pickering, M. Herbertson, and R. Gill
Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial
BMJ,
June 1, 2002;
324(7349):
1299 - 1299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kottke-Marchant and S. Sapatnekar
Hemostatic Abnormalities in Cardiopulmonary Bypass: Pathophysiologic and Transfusion Considerations
Seminars in Cardiothoracic and Vascular Anesthesia,
September 1, 2001;
5(3):
187 - 206.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M H Cross
Autotransfusion in cardiac surgery
Perfusion,
September 1, 2001;
16(5):
391 - 400.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M H Cross
Cell salvage and leucodepletion
Perfusion,
January 1, 2001;
16(1_suppl):
61 - 66.
[Abstract]
[PDF]
|
 |
|
|